NEW YORK, Sept. 21 (GenomeWeb News) - PerkinElmer and Invitrogen today said they have inked a co-marketing agreement that will integrate PerkinElmer's CellLux Fluorescence Cellular Screening Platform for cellular screening and Invitrogen's Voltage Sensor Probes ratiometric ion channel reagents.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.